Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated 9 minutes ago
Human medicines European public assessment report (EPAR): Agamree, vamorolone, Date of authorisation: 14/12/2023, Revision: 8, Status: Authorised
12 minutes ago
Human medicines European public assessment report (EPAR): Agamree, vamorolone, Date of authorisation...
Human medicines European public assessment report (EPAR): Imdylltra, tarlatamab, Date of authorisation: 29/05/2026, Status: Authorised
35 minutes ago
Human medicines European public assessment report (EPAR): Imdylltra, tarlatamab, Date of authorisation...
Human medicines European public assessment report (EPAR): Adstiladrin, nadofaragene firadenovec, Date of authorisation: 28/05/2026, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Adstiladrin, nadofaragene firadenovec, Date of...
Annex 22 expert workshop draft agenda: Day 1 - session with interested parties
about 2 hours ago
Annex 22 expert workshop draft agenda: Day 1 - session with interested...
Good manufacturing practice: Multistakeholder workshop on expert contributions to artificial intelligence guidance development (Annex 22), Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2026, 09:00 (CEST) to 1 July 2026, 17:00
about 2 hours ago
Good manufacturing practice: Multistakeholder workshop on expert contributions to artificial intelligence guidance...
Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2026, 12:30 (CEST) to 17 June 2026, 17:30 (CEST)
about 3 hours ago
Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam...
Opinion/decision on a Paediatric investigation plan (PIP): Kavigale, sipavibart, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: P/0504/2023
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Kavigale, sipavibart, decision type: PM...
Opinion/decision on a Paediatric investigation plan (PIP): Spikevax (previously COVID-19 Vaccine Moderna), elasomeran,imelsomeram,davesomeran,andusomeran SARS-CoV-2 JN.1 mRNA, decision type: PM: decision on the application for modification of an agreed PI
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Spikevax (previously COVID-19 Vaccine Moderna)...
Opinion/decision on a Paediatric investigation plan (PIP): Otezla, apremilast, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0352/2022
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Otezla, apremilast, decision type: PM...